Lupin Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Lupin Ltd.

Lupin Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.

2014

2015

2016

2017

2018

Net Income before Extraordinaries

28,317

34,148

33,288

35,431

5,468

Depreciation, Depletion & Amortization

2,610

4,347

4,871

9,122

10,859

Other Funds

238

411

920

425

144

Funds from Operations

24,570

28,896

27,323

35,180

26,074

Changes in Working Capital

4,663

949

31,593

4,913

10,173

Net Operating Cash Flow

19,907

27,947

4,270

40,093

15,901

Capital Expenditures

5,286

8,712

58,217

26,368

15,534

Sale of Fixed Assets & Businesses

402

361

636

Purchase/Sale of Investments

2,611

3,699

134

418

Net Investing Cash Flow

8,750

11,271

70,084

25,873

14,480

Cash Dividends Paid - Total

3,215

1,573

4,055

4,066

4,073

Issuance/Reduction of Debt, Net

5,298

700

62,409

9,613

8,975

Net Financing Cash Flow

8,274

1,860

59,277

5,973

12,903

Net Change in Cash

2,883

14,817

15,077

20,193

11,482

Free Cash Flow

14,620

19,235

62,487

13,725

367

Net Assets from Acquisitions

887

6,294

12,282

Change in Capital Stock

About Lupin

View Profile

Address	B/4 Laxmi Towers Mumbai Maharashtra 400051 India
Employees	-
Website	http://www.lupinworld.com
Updated	09/14/2018
Lupin Ltd. engages in the manufacture of pharmaceutical products. Its offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments.